Ana Maria Gomez1, Claudia Gomez2, Pablo Aschner2, Angelica Veloza3, Oscar Muñoz2, Claudia Rubio4, Santiago Vallejo2. 1. Pontificia Universidad Javeriana, Bogota, Colombia Hospital Universitario San Ignacio, Bogota, Colombia amgomezm5@gmail.com. 2. Pontificia Universidad Javeriana, Bogota, Colombia Hospital Universitario San Ignacio, Bogota, Colombia. 3. Clinica La Colina, Bogota, Colombia. 4. Hospital Universitario San Ignacio, Bogota, Colombia.
Abstract
BACKGROUND: Although physical exercise (PE) is recommended for individuals with type 1 diabetes (DM1), participation in exercise is challenging because it increases the risk of severe hypoglycemia and the available therapeutic options to prevent it frequently result in hyperglycemia. There is no clear recommendation about the best timing for exercise. The aim of this study was to compare the risk of hypoglycemia after morning or afternoon exercise sessions up to 36 hours postworkout. METHODS: This randomized crossover study enrolled subjects with DM1, older than 18 years of age, on sensor-augmented insulin pump (SAP) therapy. Participants underwent 2 moderate-intensity exercise sessions; 1 in the morning and 1 in the afternoon, separated by a 7 to 14 day wash-out period. Continuous glucose monitoring (CGM) data were collected 24 hours before, during and 36 hours after each session. RESULTS:Thirty-five subjects (mean age 30.31 ± 12.66 years) participated in the study. The rate of hypoglycemia was significantly lower following morning versus afternoon exercise sessions (5.6 vs 10.7 events per patient, incidence rate ratio, 0.52; 95% CI, 0.43-0.63; P < .0001). Most hypoglycemic events occurred 15-24 hours after the session. On days following morning exercise sessions, there were 20% more CGM readings in near-euglycemic range (70-200 mg/dL) than on days prior to morning exercise (P = .003). CONCLUSIONS:Morning exercise confers a lower risk of late-onset hypoglycemia than afternoon exercise and improves metabolic control on the subsequent day.
RCT Entities:
BACKGROUND: Although physical exercise (PE) is recommended for individuals with type 1 diabetes (DM1), participation in exercise is challenging because it increases the risk of severe hypoglycemia and the available therapeutic options to prevent it frequently result in hyperglycemia. There is no clear recommendation about the best timing for exercise. The aim of this study was to compare the risk of hypoglycemia after morning or afternoon exercise sessions up to 36 hours postworkout. METHODS: This randomized crossover study enrolled subjects with DM1, older than 18 years of age, on sensor-augmented insulin pump (SAP) therapy. Participants underwent 2 moderate-intensity exercise sessions; 1 in the morning and 1 in the afternoon, separated by a 7 to 14 day wash-out period. Continuous glucose monitoring (CGM) data were collected 24 hours before, during and 36 hours after each session. RESULTS: Thirty-five subjects (mean age 30.31 ± 12.66 years) participated in the study. The rate of hypoglycemia was significantly lower following morning versus afternoon exercise sessions (5.6 vs 10.7 events per patient, incidence rate ratio, 0.52; 95% CI, 0.43-0.63; P < .0001). Most hypoglycemic events occurred 15-24 hours after the session. On days following morning exercise sessions, there were 20% more CGM readings in near-euglycemic range (70-200 mg/dL) than on days prior to morning exercise (P = .003). CONCLUSIONS: Morning exercise confers a lower risk of late-onset hypoglycemia than afternoon exercise and improves metabolic control on the subsequent day.
Authors: P Galassetti; S Mann; D Tate; R A Neill; F Costa; D H Wasserman; S N Davis Journal: Am J Physiol Endocrinol Metab Date: 2001-06 Impact factor: 4.310
Authors: Michael J Tansey; Eva Tsalikian; Roy W Beck; Nelly Mauras; Bruce A Buckingham; Stuart A Weinzimer; Kathleen F Janz; Craig Kollman; Dongyuan Xing; Katrina J Ruedy; Michael W Steffes; Timothy M Borland; Ravinder J Singh; William V Tamborlane Journal: Diabetes Care Date: 2006-01 Impact factor: 19.112
Authors: Eva Tsalikian; Nelly Mauras; Roy W Beck; William V Tamborlane; Kathleen F Janz; H Peter Chase; Tim Wysocki; Stuart A Weinzimer; Bruce A Buckingham; Craig Kollman; Dongyuan Xing; Katrina J Ruedy Journal: J Pediatr Date: 2005-10 Impact factor: 4.406
Authors: Dale S Bond; Hollie A Raynor; J Graham Thomas; Jessica Unick; Jennifer Webster; Beth Ryder; Sivamainthan Vithiananthan Journal: J Phys Act Health Date: 2017-03-02
Authors: Michael R Rickels; Stephanie N DuBose; Elena Toschi; Roy W Beck; Alandra S Verdejo; Howard Wolpert; Martin J Cummins; Brett Newswanger; Michael C Riddell Journal: Diabetes Care Date: 2018-05-18 Impact factor: 19.112
Authors: Michael C Riddell; Elizabeth A Davis; Elizabeth J Mayer-Davis; Anna Kahkoska; Dessi P Zaharieva Journal: Diabetes Technol Ther Date: 2021-06 Impact factor: 7.337
Authors: Othmar Moser; Max L Eckstein; Alexander Mueller; Philipp Birnbaumer; Felix Aberer; Gerd Koehler; Caren Sourij; Harald Kojzar; Peter Holler; Helmut Simi; Peter Pferschy; Pavel Dietz; Richard M Bracken; Peter Hofmann; Harald Sourij Journal: Diabetes Obes Metab Date: 2018-10-14 Impact factor: 6.577